Show notes
Dean Henry returns to break down the peptide landscape after FDA changes, share his personal stack, and explain why biological individuality matters more than cookie-cutter protocols.
Learn why insulin has been around for 100 years as a peptide, but people don't realise the connection, how KPV and BPC work orally for gut health because they don't need to break through the bloodstream, and why stacking 18 peptides simultaneously makes no sense.
This covers Mike's first injection experience and why he wants to try retatrutide on micro-dosing, how BPC makes receptors more sensitive when…
Website: podcasters.spotify.com

